| Factor | Score | Distribution | Value | Avg | Rank |
|---|---|---|---|---|---|
Valuation | 35 | 34.4x | 17.8x | Bottom tier | |
Growth | 47 | 5.2% | 7.1% | Around median | |
Quality | 96 | 27.6% | 4.5% | Top tier | |
Safety | 68 | 1.9x | 2.6x | Top tier | |
Capital Return | 41 | 2.42% | 2.12% | Around median | |
Momentum | 56 | 10.6% | 2.9% | Around median | |
Sentiment | 43 | 12 | 3 | Around median |
Estimates — analyst targets and a simplified DCF, not investment advice.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.
Colgate-Palmolive operates through a portfolio of oral care, personal care, and home care products, alongside premium science-based pet nutrition under the Hill's Pet Nutrition brand. Growth is generated through a combination of sales volume, pricing, and premiumization, with distribution spanning traditional retail stores, e-commerce, and professional and veterinary channels; brands and products such as Colgate Total, Optic White Pro Series, Fabuloso, Elmex, Meridol, and Hill's have featured prominently in its innovation and premium-category expansion strategy.
In Q2 FY2026, the company recorded revenue of approximately $5.4 billion, gross profit of $3.3 billion, net income of $693 million, and reported earnings per share of $0.86. Reported net sales reached $5.36 billion, up 4.9%, while organic net sales grew 2.4%, and gross profit margin reached 61.5% after expanding by 140 basis points, according to the earnings report published on July 31, 2026.
Growth was broad-based, with four of five divisions and three of four categories delivering organic growth, led by emerging markets, Europe, and Hill's. Regionally, Latin America rose by approximately 5%, with volume growth of 2.6% and pricing growth of 2.8%; Brazil posted high-single-digit growth and Mexico recorded mid-single-digit growth, while North America remained weaker because of volume declines and retailer inventory reductions. Revenue for the twelve months ended in 2026 was approximately $21.0 billion, with gross profit of $12.7 billion and net income of $2.0 billion, compared with revenue of $20.4 billion and net income of $2.1 billion in FY2025.
The average analyst price target is $97.78, versus a wide range of $79 to $109 and a neutral consensus, reflecting meaningful disagreement over the impact of improving margins relative to weakness in North America and cost pressures. The average target is approximately $1.55 below the 52-week range high of $99.33, while the stock's 52-week range extends from $74.55 to $99.33; therefore, the consensus alone does not present a decisive bullish case.
Figures in the text are as of 2026-08-27; the live price is shown at the top of the page.
Colgate-Palmolive generated revenue of approximately $5.4 billion, gross profit of $3.3 billion, and net income of $693 million in Q2 FY2026. Reported earnings per share were $0.86, while the earnings report cited base earnings per share of $0.99 versus estimates of $0.95. Net sales also grew 4.9% to $5.36 billion, and gross profit margin increased to 61.5%.
India, Brazil, Mexico, and China led emerging-market growth in Q2 FY2026, while Europe made a strong contribution through innovation and premium products. Brazil posted high-single-digit growth, Mexico recorded mid-single-digit growth, and India delivered double-digit growth. Greater China also rose at a mid-single-digit rate, and Colgate China continued to deliver similar growth despite the domestic market contracting by approximately 1% to 2%.
Hill's delivered organic growth of 4% after excluding the private-label business, outperforming a category that was approximately flat, while its U.S. business also grew 4%. The exit from private label negatively affected volume by approximately 200 basis points, but volume was approximately flat after excluding this impact. Strength came from cat food, wet products, Small Paws, and therapeutic diets, with three fresh single-protein diets launched through professional and veterinary channels during the second half of FY2026.
Automated analysis for informational purposes only — not investment advice.
North America experienced category weakness during May 2026, followed by improvement in June and July 2026, but remained below historical levels. Shipments declined 3% versus consumption growth of approximately 1%, because of retailer inventory reductions alongside some market share loss and intensifying competition. The company aims to improve performance through Optic White Pro Series, Fabuloso expansions, increased brand support, and efforts to address specific pricing gaps by category and channel.
The company raised its outlook for base business earnings growth in FY2026 to the mid-single digits following its Q2 FY2026 performance. It also raised its full-year gross margin outlook from a decline to approximately flat, supported by pricing, mix, productivity, and Promo AI tools. However, it maintained cautious organic sales guidance because of demand volatility, weakness in North America, and expectations of higher raw material costs and tariffs in the second half of FY2026.
The company spent three years through July 2026 training its employees and building a secure internal artificial intelligence hub, with advanced training reaching approximately 70% of employees at the vice president level. It uses Promo AI to manage promotions and improve revenue growth, while also building data products and agents to automate complex manual processes and accelerate analysis. The company also integrates artificial intelligence into product discovery, research and development, marketing content creation, and content reuse across markets.
